Quest Diagnostics (DGX) EPS (Basic): 2009-2025
Historic EPS (Basic) for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $2.18.
- Quest Diagnostics' EPS (Basic) rose 8.46% to $2.18 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.64, marking a year-over-year increase of 14.89%. This contributed to the annual value of $7.78 for FY2024, which is 2.50% up from last year.
- Latest data reveals that Quest Diagnostics reported EPS (Basic) of $2.18 as of Q3 2025, which was down 13.15% from $2.51 recorded in Q2 2025.
- In the past 5 years, Quest Diagnostics' EPS (Basic) ranged from a high of $5.05 in Q2 2021 and a low of $0.93 during Q4 2022.
- Its 3-year average for EPS (Basic) is $2.00, with a median of $1.99 in 2023.
- Its EPS (Basic) has fluctuated over the past 5 years, first spiked by 375.68% in 2021, then crashed by 71.12% in 2022.
- Over the past 5 years, Quest Diagnostics' EPS (Basic) (Quarterly) stood at $3.22 in 2021, then slumped by 71.12% to $0.93 in 2022, then spiked by 84.95% to $1.72 in 2023, then grew by 15.12% to $1.98 in 2024, then increased by 8.46% to $2.18 in 2025.
- Its last three reported values are $2.18 in Q3 2025, $2.51 for Q2 2025, and $1.97 during Q1 2025.